Thank you for your interest in clinical trials for Polycythemia VeraPlease click "Search" to find Polycythemia Vera clinical trials and medical research studies.If you receive too many study listings you may enter your zip code to find the locations closest to you.
Your search returned no results. Get alerts when studies become available.
Your search returned 15 studies. (Get alerts for new studies):Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia Conditions: Primary Myelofibrosis - Post-Polycythemic Vera Myelofibrosis - Post-Essential Thrombocythemia Myelofibrosis8 Locations availableStudy of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative NeoplasmsConditions: Myeloproliferative Neoplasms of - Polycythemia Vera - Essential Thrombocythemia - Myelofibrosis1 Location availableHSP90 Inhibitor, AUY922, in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), Post-Essential ThrombocythemConditions: Myeloproliferative Neoplasms1 Location availableCorrelative Biomarker Study in Patients With Myeloproliferative DisordersConditions: Myeloproliferative Disease - Myelofibrosis - Idiopathic Myelofibrosis - Essential Thrombocythemia - Polycythemia Vera15 Locations availableSafety and Efficacy of Momelotinib in Subjects With Polycythemia Vera or Essential ThrombocythemiaConditions: Polycythemia Vera - Essential Thrombocythemia4 Locations availableResearch Tissue BankConditions: Myelofibrosis - Idiopathic Myelofibrosis - Essential Thrombocythemia - Polycythemia Vera9 Locations availablePegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET)Conditions: High Risk Polycythemia Vera - High Risk Essential Thrombocythemia11 Locations availableA Phase 2 Study Of PRM-151 In Subjects With MyelofibrosisConditions: Primary Myelofibrosis - Post-Polycythemia Vera Myelofibrosis - Post-Essential Thrombocythemia Myelofibrosis5 Locations availableOral Pacritinib Versus Best Available Therapy to Treat Myelofibrosis With ThrombocytopeniaConditions: Primary Myelofibrosis - Post-polycythemia Vera Myelofibrosis - Post-essential Thrombocythemia Myelofibrosis13 Locations availableFamilial Myeloproliferative DisordersConditions: Polycythemia Vera - Essential Thrombocythemia - Idiopathic Myelofibrosis5 Locations availableRuxolitinib (INCB018424) in Subjects With Primary Myelofibrosis, Post Essential Thrombocythemia-myelofibrosis and Post Polycythemia Vera-myelofibrosisConditions: Primary Myelofibrosis - Post Essential Thrombocythemia-myelofibrosis - Post Polycythemia Vera-myelofibrosis34 Locations availableRuxolitinib Prior to Transplant in Patients With MyelofibrosisConditions: Primary Myelofibrosis - Post Polycythemia Vera Myelofibrosis - Post Essential Thrombocythemia Myelofibrosis3 Locations availableEfficacy of Momelotinib Versus Best Available Therapy in Anemic or Thrombocytopenic Subjects With Primary Myelofibrosis (MF), Post-polycythemia Vera MConditions: Primary Myelofibrosis (PMF), - Post-polycythemia Vera (Post-PV) - Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)2 Locations availableRandomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)Conditions: High Risk Polycythemia Vera - High Risk Essential Thrombocythemia8 Locations availableTissue Banking Study - Polycythemia Vera or Essential Thrombocythemia (PV & ET) PatientsConditions: Polycythemia Vera - Essential Thrombocythemia1 Location available
Didn't find what you were looking for? Try these alternatives:
ClinicalConnection.com is a resource that provides individuals with information regarding clinical trials that are being conducted worldwide.
ClinicalConnection.com does not conduct these clinical trials nor endorse them. Please consult your doctor or physician before participating.